Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

61.04
Delayed Data
As of Aug 29
 -0.06 / -0.10%
Today’s Change
44.16
Today|||52-Week Range
80.64
-13.05%
Year-to-Date
Biotech ETFs in Focus After Mylan's EpiPen Controversy
Aug 26 / Zacks.com - Paid Partner Content